19 Nov 2016
The Seminar on Funding Opportunities for Translational Research was held on 19 November 2016, 2.30 pm to 4.30 pm at Academia.
The event was organised by the College of Clinician Scientists in collaboration with the National Health Innovation Centre (NHIC), National Medical Research Council (NMRC) and AstraZeneca.
The practical seminar was aimed to help clinicians, clinician-scientists and scientists understand the opportunities and practicalities of obtaining a translational research grant from NHIC and also proprietary drugs for translational research from AstraZeneca.
National Health Innovation Centre
The National Health Innovation Centre provides the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance to accelerate healthcare innovation. Established in 2014, NHIC supports the development of innovative technologies and services to improve healthcare delivery and patient care. NHIC funding aims to expedite the translation of an innovation towards a market-ready product.
NHIC-AstraZeneca Open Innovation Collaboration
NHIC and AstraZeneca’s collaboration provides Singapore’s clinical researchers with access to a curated list of AstraZeneca’s drug compounds for use in new studies to improve the understanding of a range of diseases, with a view to developing more effective treatments. The collaboration links the funding, expertise, resources and project management of AstraZeneca, NHIC and the successful research institution to provide a platform to explore novel disease pathways that would otherwise not be studied.
Dr Sharron Bennett (above photo), Head of NHIC shared with attendees on how NHIC could provide translational funding and support for Clinician Scientists. She also presented projects and case studies that NHIC have funded.
Mr How Ti Hwei (above photo), Country President Singapore at AstraZeneca was one of the speakers at the seminar. He touched on pushing boundaries of science to deliver life-changing medicines.
Dr Donna Tan (above photo), Medical Advisor at AstraZeneca talked about pushing the boundaries of science through open innovation.
There were about 30 attendees who attended the Saturday afternoon seminar.
The College of Clinician Scientists would like to thank NHIC, NMRC and AstraZenca along with those who attended the seminar for making the event a success.
Please click here for the programme flyer and registration form.
